Oxidative Stress Inhibits Melanoma Cell Metastasis

This article originally appeared here.
Oxidative Stress Inhibits Metastasis by Melanoma Cells
Oxidative Stress Inhibits Metastasis by Melanoma Cells

(HealthDay News) -- Oxidative stress inhibits metastasis by melanoma cells, according to an experimental study published online Oct. 14 in Nature.

Elena Piskounova, Ph.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues analyzed human melanomas that differed in their metastasis histories in patients and in their capacity to metastasize in NOD-SCID-Il2rg−/− (NSG) mice.

The researchers found that the melanomas had high frequencies of cells that formed subcutaneous tumors, but lower percentages of cells that formed tumors following intravenous or intrasplenic transplantation; this was especially true for melanomas that metastasized inefficiently. Oxidative stress was seen in melanoma cells in the blood and visceral organs, but not in established subcutaneous tumor. During metastasis, successfully metastasizing melanomas underwent reversible metabolic changes, which increased their capacity to withstand oxidative stress, including elevated dependence on NADPH-generating enzymes within the folate pathway. Distant metastasis was promoted by antioxidants in NSG mice. Inhibition of folate pathway correlated with inhibition of distant metastasis with no significant effect on the growth of subcutaneous tumors in the same mice.

"Our results suggest that antioxidants promote disease progression, at least in melanoma, by promoting metastasis," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, several of which provided study medication, equipment, or supplies.

Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs